Peptonic Medical AB (publ) (“Peptonic”) announced today that the company’s patented product for self-testing of bacterial vaginosis, VagiVital VS, is being offered for sale in
Today, November 2, 2023 the exercise period for warrants of series TO3 begins in PEPTONIC medical AB (“Peptonic” or the “Company”). The exercise period lasts
NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, JAPAN, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SOUTH KOREA,
Peptonic CEO Erik Sundquist presented the company on Biostock Life Summit Event in Lund October 26, 2023. If you were unable to see the event
Peptonic Medical AB (publ) today announced that CEO Erik Sundquist will present the company at the BioStock Life Science Fall Summit in Lund, Sweden, on
QUARTERLY REPORT Period January – September 2023 PEPTONIC Medical AB (publ) org nr 556776–3064 (www.spotlightstockmarket.com, ticker: PMED) GROUP 2023 THIRD QUARTER (Jul-Sep) 2023 FIRST NINE
